0
Applications of Functional Imaging to Carbon Monoxide Poisoning
Robin A. Hurley, M.D.; Ramona O. Hopkins, Ph.D.; Erin D. Bigler, Ph.D.; Katherine H. Taber, Ph.D.
The Phenomenology of Personality Change Due to Traumatic Brain Injury in Children and Adolescents
Jeffrey Edwin Max, M.B.B.Ch.; Brigitte Anna Marie Robertson, M.D.; Amy E. Lansing, Ph.D.
The Clinical Role of Computerized EEG in the Evaluation and Treatment of Learning and Attention Disorders in Children and Adolescents
Robert J. Chabot, Ph.D.; Flavia di Michele, M.D.; Leslie Prichep, Ph.D.; E. Roy John, Ph.D.
Prevalence, Clinical Manifestations, Etiology, and Treatment of Depression in Parkinson's Disease
James R. Slaughter, M.D.; Kathleen A. Slaughter, B.S.N.R.N.C.; Dave Nichols, B.S.; Stacey E. Holmes, M.A.; Matthew P. Martens, M.A.
EEG Monitoring in Depressed Patients Undergoing Repetitive Transcranial Magnetic Stimulation
Nashaat N. Boutros, M.D.; Alexander P. Miano, M.D.; Ralph E. Hoffman, M.D.; Robert M. Berman, M.D.
Prefrontal Cortex Modulation of Mood and Emotionally Induced Facial ExpressionsA Transcranial Magnetic Stimulation Study
Frank Padberg, M.D.*; Georg Juckel, M.D.*; Anuschka Präßl, M.D.; Peter Zwanzger, M.D.; Paraskevi Mavrogiorgou, M.D.; Ulrich Hegerl, M.D.; Harald Hampel, M.D.; Hans-Jürgen Möller, M.D.
Reduced Hippocampal Volume in Association With P50 Nonsuppression Following Traumatic Brain Injury
David B. Arciniegas, M.D.; Jeannie L. Topkoff, B.S.; Donald C. Rojas, Ph.D.; Jeanelle Sheeder, B.A.; Peter Teale, M.S.E.E.; David A. Young, Ph.D.; Elliot Sandberg, M.D.; Martin L. Reite, M.D.; Lawrence E. Adler, M.D.
In Vivo Evidence for Differential Association of Striatal Dopamine and Midbrain Serotonin Systems With Neuropsychiatric Symptoms in Parkinson's Disease
Toshiya Murai, M.D.; Ulrich Müller, M.D.; Katja Werheid, M.A.; Dietlind Sorger; Mike Reuter, M.D.; Thomas Becker, M.D.; D. Yves von Cramon, M.D.; Henryk Barthel, M.D.
Validation of the Delirium Rating Scale-Revised-98Comparison With the Delirium Rating Scale and the Cognitive Test for Delirium
Paula T. Trzepacz, M.D.; Dinesh Mittal, M.D.; Rafael Torres, M.D.; Kim Kanary, B.S.; John Norton, M.D.; Nita Jimerson, M.S.N.
Methylphenidate Improves HIV-1–Associated Cognitive Slowing
Charles H. Hinkin, Ph.D.; Steven A. Castellon, Ph.D.; David J. Hardy, Ph.D.; Roxanna Farinpour, Ph.D.; Thomas Newton, M.D.; Elyse Singer, M.D.
Specific Frontal Lobe Subregions Correlated With Unawareness of Illness in SchizophreniaA Preliminary Study
Laura A. Flashman, Ph.D.; Thomas W. McAllister, M.D.; Sterling C. Johnson, Ph.D.; Jacqueline H. Rick, B.A.; Ronald L. Green, M.D.; Andrew J. Saykin, Psy.D.
Dentatorubral-Pallidoluysian Atrophy (DRPLA) Presenting With Psychosis
Naoto Adachi, M.D.; Kunimasa Arima, M.D.; Takashi Asada, M.D.; Masaaki Kato, M.D.; Narihiro Minami, M.D.; Yu-ichi Goto, M.D.; Teiichi Onuma, M.D.; Takeshi Ikeuchi, M.D.; Shoji Tsuji, M.D.; Masahiro Hayashi, M.D.; Yuken Fukutani, M.D.
Clonic Seizure Associated With High Clozapine Plasma Level
G. Dumortier, Pharm.D., Ph.D.; V. MahÉ; D. Pons; A Zerrouk; D. Januel; K. Degrassat
Cognitive and Neuropsychiatric Side Effects of Mefloquine
Debbie J. Javorsky, Ph.D.; Geoffrey Tremont, Ph.D.; Gabor I. Keitner, M.D.; A. Hilton Parmentier, M.D.
Intravenous Valproic Acid in the Treatment of Severe Catatonia
Stephanie KrÜger, M.D.; Peter BrÄunig, M.D.
Celecoxib- and Rofecoxib-Induced Delirium
Chris MacKnight, M.D., M.Sc., F.R.C.P.C.; Carlos H. Rojas-Fernandez, Pharm.D.